Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Obesity and prostate cancer screening among African-American and Caucasian men.

Fowke JH, Signorello LB, Underwood W 3rd, Ukoli FA, Blot WJ.

Prostate. 2006 Sep 15;66(13):1371-80.

PMID:
16752375
2.

Effects of obesity and height on prostate-specific antigen (PSA) and percentage of free PSA levels among African-American and Caucasian men.

Fowke JH, Signorello LB, Chang SS, Matthews CE, Buchowski MS, Cookson MS, Ukoli FM, Blot WJ.

Cancer. 2006 Nov 15;107(10):2361-7.

3.

Prostate cancer screening between low-income African-American and Caucasian men.

Fowke JH, Schlundt D, Signorello LB, Ukoli FA, Blot WJ.

Urol Oncol. 2005 Sep-Oct;23(5):333-40.

PMID:
16144667
4.

The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.

Culp S, Porter M.

BJU Int. 2009 Nov;104(10):1457-61. doi: 10.1111/j.1464-410X.2009.08646.x. Epub 2009 Jun 12.

5.

Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey.

Ross LE, Berkowitz Z, Ekwueme DU.

Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):636-44. doi: 10.1158/1055-9965.EPI-07-2709.

6.

Body mass index and cancer screening in older American Indian and Alaska Native men.

Muus KJ, Baker-Demaray T, McDonald LR, Ludtke RL, Allery AJ, Bogart TA, Goldberg J, Ramsey SD, Buchwald DS.

J Rural Health. 2009 Winter;25(1):104-8. doi: 10.1111/j.1748-0361.2009.00206.x.

PMID:
19166569
7.

The effects of body mass index on changes in prostate-specific antigen levels and prostate volume over 15 years of follow-up: implications for prostate cancer detection.

Wallner LP, Morgenstern H, McGree ME, Jacobson DJ, St Sauver JL, Jacobsen SJ, Sarma AV.

Cancer Epidemiol Biomarkers Prev. 2011 Mar;20(3):501-8. doi: 10.1158/1055-9965.EPI-10-1006. Epub 2011 Jan 17.

8.

Obesity and prostate cancer detection: insights from three national surveys.

Parekh N, Lin Y, Dipaola RS, Marcella S, Lu-Yao G.

Am J Med. 2010 Sep;123(9):829-35. doi: 10.1016/j.amjmed.2010.05.011.

9.

Relationship between prostate-specific antigen and obesity in prostate cancer screening: analysis of a large cohort in Japan.

Kubota Y, Seike K, Maeda S, Shinohara Y, Iwata M, Sugimoto N.

Int J Urol. 2011 Jan;18(1):72-5. doi: 10.1111/j.1442-2042.2010.02667.x. Epub 2010 Nov 18.

11.

Obesity and screening PSA levels among men undergoing an annual physical exam.

Rundle A, Neugut AI.

Prostate. 2008 Mar 1;68(4):373-80. doi: 10.1002/pros.20704.

PMID:
18189231
12.

Prostate-specific antigen screening among young men in the United States.

Scales CD Jr, Antonelli J, Curtis LH, Schulman KA, Moul JW.

Cancer. 2008 Sep 15;113(6):1315-23. doi: 10.1002/cncr.23667.

13.

Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.

Freedland SJ, Sun L, Kane CJ, Presti JC Jr, Terris MK, Amling CL, Moul JW, Aronson WJ.

BJU Int. 2008 Sep;102(8):969-74. doi: 10.1111/j.1464-410X.2008.07934.x. Epub 2008 Aug 7.

14.

A population-based survey of prostate-specific antigen testing among California men at higher risk for prostate carcinoma.

Spencer BA, Babey SH, Etzioni DA, Ponce NA, Brown ER, Yu H, Chawla N, Litwin MS.

Cancer. 2006 Feb 15;106(4):765-74.

15.

Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic.

Price MM, Hamilton RJ, Robertson CN, Butts MC, Freedland SJ.

Urology. 2008 May;71(5):787-91. doi: 10.1016/j.urology.2007.11.036. Epub 2008 Feb 11.

PMID:
18267334
16.

Association of healthcare barriers with prostate-specific antigen screening among African-American and Afro-Caribbean men.

Lee DJ, Consedine NS, Gonzalez JR, Spencer BA.

Urology. 2012 Sep;80(3):556-63. doi: 10.1016/j.urology.2012.02.085. Epub 2012 Jul 11.

PMID:
22789295
17.

Recruitment strategies and comparison of prostate cancer-specific clinical data on African-American and Caucasian males with and without family history.

Mandal DM, Sartor O, Halton SL, Mercante DE, Bailey-Wilson JE, Rayford W.

Prostate Cancer Prostatic Dis. 2008;11(3):274-9. doi: 10.1038/pcan.2008.5. Epub 2008 Feb 12.

18.

[Relationship between serum prostate-specific antigen levels and body mass index in Beijing men over 50 years of age].

Wang Y, Zhou Z, Tian Y, Shao Q, Chen S, Hong BF, Zhang XH, Ren XH, Sun WX, Wang ZW, Na YQ.

Zhonghua Yi Xue Za Zhi. 2009 Jun 23;89(24):1681-3. Chinese.

PMID:
19957525
19.

Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.

Hutterer G, Perrotte P, Gallina A, Walz J, Jeldres C, Traumann M, Suardi N, Saad F, BĂ©nard F, Valiquette L, McCormack M, Graefen M, Montorsi F, Karakiewicz PI.

Eur J Cancer. 2007 May;43(7):1180-7. Epub 2007 Feb 9.

PMID:
17292604
20.

Physician-patient discussions with african american men about prostate cancer screening.

Ross LE, Powe BD, Taylor YJ, Howard DL.

Am J Mens Health. 2008 Jun;2(2):156-64. doi: 10.1177/1557988307309323. Epub 2007 Dec 5.

PMID:
19477779
Items per page

Supplemental Content

Write to the Help Desk